MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Baseline predictors of clinical and imaging progression in Parkinson’s disease: Results from the PPMI study

    L. Chahine, A. Siderowf, C. Caspell-Garcia, J. Barnes, N. Seedorff, C. Coffey, D. Galasko, B. Mollenhauer, V. Arnedo, N. Daegele, M. Frasier, C. Tanner, K. Kieburtz, K. Marek (Pittsburgh, PA, USA)

    Objective: To identify clinical, imaging, and biochemical measures, obtained early in the disease course that predict clinical and dopamine transporter (DAT) imaging progression in PD.…
  • 2018 International Congress

    Pronounced synucleinopathy and nigrostriatal degeneration result in forelimb use deficits in the rat preformed alpha-synuclein fibril model

    J. Patterson, M. Duffy, T. Collier, K. Luk, C. Kemp, J. Howe, P. Patel, A. Stoll, K. Miller, N. Kanaan, K. Paumier, C. Sortwell (Grand Rapids, MI, USA)

    Objective: Generation of a synucleinopathy model in rats using injections of α-synuclein preformed fibrils (α-syn PFFs) resulting in robust and widespread α-syn pathology and at…
  • 2018 International Congress

    Speech and Language Therapy (SLT) for Inpatients with Parkinson’s (IwP) in a Large District General Hospital

    J. Martin, A. Chatterjee (Reading, United Kingdom)

    Objective: To improve access to SLT for the MDT and IwP at the Royal Berkshire Hospital. Background: A successful bid in Jan 2017 for a…
  • 2018 International Congress

    Is there a role for miRNA in the diagnosis of PD?

    A. Garvey, N. Cutfield, J. Williams (Dunedin, New Zealand)

    Objective: Several studies have examined mirco RNA (miRNA) in Parkinson's disease with the aim of finding a diagnostic test; so what utility have miRNA in…
  • 2018 International Congress

    Spectrum of movement disorders in patients of autoimmune encephalitis of non-neoplastic aetiology

    D. Dash, M. Tripathi, K. Ihtisham (Delhi, India)

    Objective: To study the spectrum of movement disorders and the response to immunotherapy in patients of autoimmune encephalitis of non-neoplastic aetiology. Background: Antibody mediated non…
  • 2018 International Congress

    A Case of Parkinsonism due to the Hypoxic-Ischemic Lesions of the Striatum

    H. Kaleagasi, N. Oksuz, O. Dogu (Mersin, Turkey)

    Objective: To present a case of parkinsonism due to the hypoxic-ischemic lesions of the striatum. Background: Parkinsonism due to the basal ganglia lesions caused by…
  • 2018 International Congress

    Cognitive impairment in multiple system atrophy: A Nepalese tertiary center study

    R. Ojha, K. Oli (Kathmandu, Nepal)

    Objective: This study was done to describe the clinical profile of MSA and evaluate the cognitive function using mini-mental state examination(MMSE). Background: Multiple system atrophy…
  • 2018 International Congress

    Progressive Supranuclear Palsy and Eye of the Tiger Sign

    O. Dogu, H. Genç, N. Öksüz (Mersin, Turkey)

    Objective: To report a typical progressive supranuclear palsy case with "eye of the tiger sign" on MRI Background: Progressive supranuclear palsy (PSP); is a degenerative…
  • 2018 International Congress

    Evolution of diagnostic certainty and PSP-predominance types in 187 pathologically confirmed PSP patients

    M. Grimm, G. Respondek, I. Piot, T. Arzberger, Y. Compta, E. Englund, L. Ferguson, E. Gelpi, A. Giese, S. Roeber, D. Irwin, W. Meissner, C. Nilsson, A. Pantelyat, A. Rajput, C. Troakes, G. Höglinger (Munich, Germany)

    Objective: To examine the evolution of diagnostic certainty and clinical predominance types as defined by the movement disorder society (MDS) criteria for the clinical diagnosis…
  • 2018 International Congress

    PBT434 prevents the accumulation of glial cell inclusions and insoluble alpha-synuclein in a mouse model of Multiple System Atrophy

    D. Finkelstein, P. Adlard, N. Stefanova, D. Stamler (Parkville, Vic, Australia)

    Objective: To evaluate PBT434 in a transgenic mouse model of multiple system atrophy (MSA) Background: PBT434 is a novel quinazolinone inhibitor of iron-mediated protein accumulation…
  • « Previous Page
  • 1
  • …
  • 59
  • 60
  • 61
  • 62
  • 63
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley